Literature DB >> 16998712

Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli.

A M Marini1, X Jiang, X Wu, H Pan, Z Guo, M P Mattson, N Blondeau, A Novelli, R H Lipsky.   

Abstract

The amino acid glutamate, the major excitatory neurotransmitter in the central nervous system, activates receptors coupled to calcium influx. Excessive activation of glutamate receptors in conditions such as severe epileptic seizures or stroke can kill neurons in a process called excitotoxicity. However, subtoxic levels of activation of the N-methyl-D-aspartate (NMDA) type of glutamate receptor elicit adaptive responses in neurons that enhance their ability to withstand more severe stress. A variety of stimuli induce adaptive responses to protect neurons. For example, sublethal ischemic episodes or a mild epileptic insult can protect neurons in a process referred to as tolerance. The molecular mechanisms that protect neurons by these different stressful stimuli are largely unknown but they share common features such as the transcription factor, nuclear factor kappa B (NF-kappaB), which is activated by ischemic and epileptic preconditioning as well as exposure to subtoxic NMDA concentrations. In this article, we describe stress-induced neuroprotective mechanisms highlighting the role of brain-derived neurotrophic factor (BDNF), a protein that plays a crucial role in neuronal survival and maintenance, neurogenesis and learning and memory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998712     DOI: 10.1007/s00726-006-0414-y

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  35 in total

Review 1.  Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.

Authors:  Paul A Lapchak
Journal:  Expert Rev Med Devices       Date:  2012-01       Impact factor: 3.166

2.  Enhanced hypoxic preconditioning by isoflurane: signaling gene expression and requirement of intracellular Ca2+ and inositol triphosphate receptors.

Authors:  Philip E Bickler; Christian S Fahlman
Journal:  Brain Res       Date:  2010-04-29       Impact factor: 3.252

3.  Hypobaric Preconditioning Modifies Group I mGluRs Signaling in Brain Cortex.

Authors:  Dmitry G Semenov; Alexandr V Belyakov; Tatjana S Glushchenko; Mikhail O Samoilov; Elzbieta Salinska; Jerzy W Lazarewicz
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

Review 4.  Hormesis defined.

Authors:  Mark P Mattson
Journal:  Ageing Res Rev       Date:  2007-12-05       Impact factor: 10.895

5.  Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals.

Authors:  Mark P Mattson; Tae Gen Son; Simonetta Camandola
Journal:  Dose Response       Date:  2007-08-06       Impact factor: 2.658

6.  Expression of signal transduction genes differs after hypoxic or isoflurane preconditioning of rat hippocampal slice cultures.

Authors:  Philip E Bickler; Christian S Fahlman
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

Review 7.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 8.  Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan.

Authors:  S M Rothman; M P Mattson
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

9.  Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum.

Authors:  Jean Lud Cadet; Michael T McCoy; Ning Sheng Cai; Irina N Krasnova; Bruce Ladenheim; Genevieve Beauvais; Natascha Wilson; William Wood; Kevin G Becker; Amber B Hodges
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

10.  Status epilepticus affects the gigantocellular network of the pontine reticular formation.

Authors:  Péter Baracskay; Viola Kiglics; Katalin A Kékesi; Gábor Juhász; András Czurkó
Journal:  BMC Neurosci       Date:  2009-11-13       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.